NeoGenomics Inc (NEO) — Free Cash Flow Generation Index
NeoGenomics Inc (NEO) has a Free Cash Flow Generation Index of -4.86x as of December 2025. Free cash flow of $-6.53 Million represents -5% of operating cash flow ($1.34 Million). See NEO working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
NeoGenomics Inc Free Cash Flow Generation Index (2011–2025)
Historical FCF Generation Index trend for NeoGenomics Inc across 11 annual periods. Explore NEO operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for NeoGenomics Inc (2011–2025)
Year-by-year Free Cash Flow Generation Index for NeoGenomics Inc. For the full company profile including market capitalisation, see NeoGenomics Inc market cap and net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.16x | $-21.78 Million | $5.23 Million | $27.01 Million | ▲ +14.1% |
| 2024 | -4.85x | $-34.04 Million | $7.02 Million | $41.06 Million | ▲ +74.4% |
| 2020 | -18.93x | $-27.64 Million | $1.46 Million | $29.10 Million | ▼ -13343.9% |
| 2019 | 0.14x | $3.34 Million | $23.37 Million | $20.03 Million | ▼ -79.0% |
| 2018 | 0.68x | $30.48 Million | $44.79 Million | $14.31 Million | ▲ +182.4% |
| 2017 | 0.24x | $4.35 Million | $18.04 Million | $13.69 Million | ▼ -62.9% |
| 2016 | 0.65x | $13.94 Million | $21.48 Million | $7.54 Million | ▼ -0.7% |
| 2015 | 0.65x | $4.18 Million | $6.39 Million | $2.21 Million | ▲ +8.8% |
| 2014 | 0.60x | $5.68 Million | $9.45 Million | $3.77 Million | ▲ +519.5% |
| 2013 | 0.10x | $216.00K | $2.23 Million | $2.01 Million | ▲ +100.8% |
| 2011 | -12.00x | $-828.00K | $69.00K | $897.00K | — |